News

As the EU patent expires on its flagship respiratory diseases product, Spiriva, Boehringer Ingelheim is looking to newer diabetes and respiratory drugs under the leadership of a new CEO. Formerly ...
Inhaled corticosteroids, such as Arnuity Ellipta (fluticasone) or Pulmicort (budesonide); Combination meds with an ICS and LABA option to relax and open airways, like Advair (fluticasone with ...
A long-term real-world study of older adults with COPD shows that initiation of tiotropium is linked to a minimal increase in dementia risk, which is unlikely to outweigh its clinical benefits.
Lupin has signed a license and supply agreement with Sino Universal Pharmaceuticals for the commercialization of tiotropium dry powder inhaler, 18 mcg/capsule, in the Chinese market, for the ...
Some forms of exercise are likelier than others to trigger asthma symptoms. Learn more from WebMD about preventing symptoms before, during, and after a workout.
The company has entered into a license and supply agreement with Sino Universal Pharmaceuticals (SUP) for the commercialization of Tiotropium Dry Powder Inhaler (DPI), 18 mcg/capsule.
Tiotropium DPI is known for its efficacy in improving lung function and quality of life for patients suffering from respiratory conditions. This partnership will enable Lupin to expand its footprint ...
The clinical trial safety database for tiotropium has been augmented with a 4-year trial in patients with COPD, ... 2010 spiriva-handihaler-spiriva-respimat-tiotropium-343446 ...
Lupin has signed a licensing deal with China’s Sino Universal Pharmaceuticals to bring its Tiotropium inhaler to the Chinese market. The product, used for treating COPD, will be manufactured by ...
Sidebar Key Issues. Substantial evidence now supports the causative role of bacteria in exacerbations and provides the theoretical basis for the use of antibiotics in acute exacerbations of chronic ...
Learn about COPD medications, including bronchodilators, steroids, and combination treatments. Understand how they work, their side effects, and ways to manage COPD effectively.
Context: Primary care physicians provide care for the majority of patients with mild-to-moderate chronic obstructive pulmonary disease (COPD). Although clinical practice guidelines have been developed ...